Key result
A 10-day treatment with taxifolin (20 mg/kg/day) reduced blood pressure in spontaneously hypertensive rats, likely via improved endothelium-dependent relaxation and reduced inflammation.
Why the study?
Does taxifolin reduce blood pressure and improve vascular function in spontaneously hypertensive rats?
Does taxifolin reduce blood pressure and improve vascular function in spontaneously hypertensive rats?
Taxifolin reduces blood pressure in spontaneously hypertensive rats, likely through improved endothelium-dependent relaxation and modulation of inflammatory pathways.
Should not yet inform clinical use; leaves open taxifolin's antihypertensive potential in humans.
The effect of a 10-day-long treatment with taxifolin (TAX, 20 mg/kg/day p.o.) was investigated on spontaneously hypertensive rats (SHRs) with a focus on the vascular functions of isolated femoral arteries and thoracic aortas. TAX reduced blood pressure in SHRs. In femoral arteries, TAX increased acetylcholine-induced relaxation, reduced the maximal NA-induced contraction, and reduced acetylcholine-induced endothelium-dependent contraction (EDC); however, TAX had no effect on the vascular reactivity of isolated thoracic aortas. In addition, TAX elevated the total nitric oxide synthase (NOS) activity and iNOS protein expression but reduced cyclooxygenase-2 (COX2) protein expression in the tissue of the abdominal aorta without changes in Nos2 and Ptgs2 gene expressions. TAX also increased the gene expression of the anti-inflammatory interleukin-10 (Il10). In addition, in vitro studies showed that TAX has both electron donor and H atom donor properties. However, TAX failed to reduce superoxide production in the tissue of the abdominal aorta after oral administration. In conclusion, our results show that a decrease in the blood pressure in TAX-treated SHRs might be attributed to improved endothelium-dependent relaxation and reduced endothelium-dependent contraction. In addition, the results suggest that the effect of TAX on blood pressure regulation also involves the attenuation of COX2-mediated pro-inflammation and elevation of anti-inflammatory pathways.
No takes yet. Share an insight, caveat, or question.
Líšková et al. (2023) studied Hypertension (Spontaneously hypertensive rats). Taxifolin was evaluated on Blood pressure and vascular function. A 10-day treatment with taxifolin (20 mg/kg/day) reduced blood pressure in spontaneously hypertensive rats, likely via improved endothelium-dependent relaxation and reduced inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: